Upadacitinib
規格
1310726-60-3CAS番号
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamideIUPAC名
C17H19F3N6O化学式
380.4 g/mol分子量
Upadacitinib; 1310726-60-3; ABT-494; Upadacitinib anhydrous; 4RA0KN46E0; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; DTXSID901027919; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; upadacitinibum; RefChem:57163; L04AA44; DTXCID401513480; (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; Rinvoq; (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; ABT 494; UNII-4RA0KN46E0; C17H19F3N6O; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; Upadacitinib [USAN]; Upadacitinib (Standard); UPADACITINIB [MI]; Upadacitinib, ABT-494; Upadacitinib (USAN/INN); UPADACITINIB [INN]; Upadacitinib [USAN:INN]; Upadacitinib (ABT-494); UPADACITINIB [WHO-DD]; GTPL9246; orb1299762; SCHEMBL9991056; CHEMBL3622821; WYQFJHHDOKWSHR-MNOVXSKESA-N; GLXC-10425; UPADACITINIB [ORANGE BOOK]; EX-A1628; BDBM50503287; EBC-26865; HY-19569R; s8162; AKOS030567686; CS-6150; DB15091; ABBV-599 COMPONENT UPADACITINIB; NCGC00588874-01; AC-30326; AS-56379; DA-78788; FA166721; HY-19569; NS00133778; T7503; C72237; D10994; F797290; Q27074125; Z2831495606; (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide; 1831899-72-9; ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide別名
Upadacitinibを含む製品
CHEMISTRY Discover Molecule InsightsUpadacitinib(Semihydrate)Upadacitinib TabletsUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUPADACITINIB
1/3ページ
Upadacitinibに関連するサービス
Upadacitinibを販売する企業
HR
Hangzhou Royall Import & Export Co.,LtdChinaJM
Jiangsu Magic Biotechnology Co., LtdChinaCP
CHENGHUI PHARMACEUTICAL GROUP LTDChinaSI
Sinoway Industrial Co.Ltd.ChinaSI
Shanghai IntVal Chemicals Co., LtdChinaRG
ROUNDCARE GROUPChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaSG
Sichuan Gowell Pharmaceutical Co., Ltd.ChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChina1/2ページ